Works by Pérol, Maurice

Results: 29

The safety and efficacy of ramucirumab in combination with docetaxel in the treatment of lung cancer.

Published in:

2016

By:

Paulus, Valérie;
Avrillon, Virginie;
Pérol, Maurice;
Paulus, Valérie;
Pérol, Maurice

Publication type:

journal article

Bulletin de synthèse de veille 2006.

Published in:

Oncologie (Tech Science Press), 2007, v. 9, n. 4, p. 313, doi. 10.1007/s10269-007-0649-6

By:

Bugat, Roland;
Planchamp, François;
Lesimple, Thierry;
Voigt, Jean-Jacques;
Culine, Stéphane;
Lortholary, Alain;
Merrouche, Yacine;
Ganem, Gérard;
Kaminsky, Marie-Christine;
Négrier, Sylvie;
Pérol, Maurice;
Fizazi, Karim;
Blot, Emmanuel

Publication type:

Article

Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort.

Published in:

International Journal of Environmental Research & Public Health, 2018, v. 15, n. 1, p. 65, doi. 10.3390/ijerph15010065

By:

Pérol, Olivia;
Charbotel, Barbara;
Perrier, Lionel;
Bonnand, Sandrine;
Belladame, Elodie;
Avrillon, Virginie;
Rebattu, Paul;
Gomez, Frédéric;
Lauridant, Géraldine;
Pérol, Maurice;
Fervers, Beatrice

Publication type:

Article

Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study.

Published in:

Supportive Care in Cancer, 2021, v. 29, n. 1, p. 117, doi. 10.1007/s00520-020-05459-0

By:

Garon, Edward B.;
Winfree, Katherine B.;
Molife, Cliff;
Cui, Zhanglin Lin;
Arriola, Edurne;
Levy, Benjamin;
Mekhail, Tarek;
Pérol, Maurice

Publication type:

Article

Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review.

Published in:

JAMA Network Open, 2021, v. 4, n. 12, p. e2139573, doi. 10.1001/jamanetworkopen.2021.39573

By:

Filleron, Thomas;
Bachelier, Marine;
Mazieres, Julien;
Pérol, Maurice;
Meyer, Nicolas;
Martin, Elodie;
Mathevet, Fanny;
Dauxois, Jean-Yves;
Porcher, Raphael;
Delord, Jean-Pierre

Publication type:

Article

High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.747692

By:

Takam Kamga, Paul;
Swalduz, Aurélie;
Costantini, Adrien;
Julié, Catherine;
Emile, Jean-François;
Pérol, Maurice;
Avrillon, Virginie;
Ortiz-Cuaran, Sandra;
de Saintigny, Pierre;
Leprieur, Etienne Giroux

Publication type:

Article

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.

Published in:

PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234302

By:

Remon, Jordi;
Swalduz, Aurelie;
Planchard, David;
Ortiz-Cuaran, Sandra;
Mezquita, Laura;
Lacroix, Ludovic;
Jovelet, Cecile;
Rouleau, Etienne;
Leonce, Camille;
De Kievit, Frank;
Morris, Clive;
Jones, Greg;
Mercier, Kelly;
Howarth, Karen;
Green, Emma;
Pérol, Maurice;
Saintigny, Pierre;
Besse, Benjamin

Publication type:

Article

Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer.

Published in:

2018

By:

Smit, Egbert F.;
Garon, Edward B.;
Reck, Martin;
Cappuzzo, Federico;
Bidoli, Paolo;
Cohen, Roger B.;
Gao, Ling;
O’Brien, Lisa M.;
Lee, Pablo;
Zimmermann, Annamaria;
Ferry, David R.;
Melemed, Allen S.;
Pérol, Maurice;
O'Brien, Lisa M

Publication type:

journal article

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1526931

By:

Justeau, Grégoire;
Chouaid, Christos;
Debieuvre, Didier;
Audigier-Valette, Clarisse;
Quantin, Xavier;
Léna, Hervé;
Bosquet, Lise;
Girard, Nicolas;
Schoemaker, Minouk J.;
Mella, Marta;
Pinto Correia, Bárbara;
Rault, Caroline;
Daumont, Melinda J.;
Penrod, John R.;
Lee, Adam;
Pérol, Maurice

Publication type:

Article

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.

Published in:

Targeted Oncology, 2023, v. 18, n. 4, p. 585, doi. 10.1007/s11523-023-00976-4

By:

Babey, Hélène;
Jamme, Philippe;
Curcio, Hubert;
Assié, Jean Baptiste;
Veillon, Remi;
Doubre, Hélène;
Pérol, Maurice;
Guisier, Florian;
Huchot, Eric;
Decroisette, Chantal;
Falchero, Lionel;
Corre, Romain;
Cortot, Alexis;
Chouaïd, Christos;
Descourt, Renaud

Publication type:

Article

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 801, doi. 10.1007/s11523-021-00848-9

By:

Chouaid, Christos;
Filleron, Thomas;
Debieuvre, Didier;
Pérol, Maurice;
Girard, Nicolas;
Dansin, Eric;
Lena, Hervé;
Gervais, Radj;
Cousin, Sophie;
Otto, Josiane;
Schott, Roland;
Planchard, David;
Madroszyk, Anne;
Kaderbhai, Courèche;
DUBRAY-Longeras, Pascale;
Hiret, Sandrine;
Pichon, Eric;
Clément-Duchêne, Christelle;
Chenuc, Gaëlle;
Simon, Gaëtane

Publication type:

Article

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.

Published in:

2018

By:

Saboundji, Karima;
Auliac, Jean-Bernard;
Pérol, Maurice;
François, Géraldine;
Janicot, Henri;
Marcq, Marie;
Dubos-Arvis, Catherine;
Renault, Aldo;
Guisier, Florian;
Odier, Luc;
Gervais, Radj;
Chouaïd, Christos

Publication type:

journal article

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.

Published in:

OncoImmunology, 2017, v. 6, n. 9, p. N.PAG, doi. 10.1080/2162402X.2017.1339856

By:

Kaderbhai, Courèche-Guillaume;
Richard, Corentin;
Fumet, Jean David;
Aarnink, Anne;
Ortiz-Cuaran, Sandra;
Pérol, Maurice;
Foucher, Pascal;
Coudert, Bruno;
Favier, Laure;
Lagrange, Aurélie;
Limagne, Emeric;
Boidot, Romain;
Ladoire, Sylvain;
Poudenx, Michel;
Ilie, Marius;
Hofman, Paul;
Saintigny, Pierre;
Ghiringhelli, François

Publication type:

Article

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer.

Published in:

Cancers, 2020, v. 12, n. 11, p. 3112, doi. 10.3390/cancers12113112

By:

Gobbini, Elisa;
Swalduz, Aurélie;
Giaj Levra, Matteo;
Ortiz-Cuaran, Sandra;
Toffart, Anne-Claire;
Pérol, Maurice;
Moro-Sibilot, Denis;
Saintigny, Pierre

Publication type:

Article

Expérience de suivi à domicile des patients atteints d'un cancer et traités par immunothérapie.

Published in:

Bulletin Infirmier du Cancer, 2021, v. 21, n. 2, p. 47, doi. 10.1684/bic.2021.149

By:

Berlioz, Marie;
Galen, Claire;
Leclere-Condis, Bénédicte;
Montagnier, Virginie;
Morlière, Lise;
Pérol, Maurice;
Remy, Carinne;
Salignat, Annick;
Sontag, Pascale

Publication type:

Article

Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report.

Published in:

Clinical Lung Cancer, 2023, v. 24, n. 1, p. 72, doi. 10.1016/j.cllc.2022.10.005

By:

Gazeu, Alexia;
Aubert, Mylena;
Pissaloux, Daniel;
Lantuejoul, Sylvie;
Pérol, Maurice;
Ikhlef, Nadia;
Bouhamama, Amine;
Franceschi, Tatiana;
Swalduz, Aurèlie

Publication type:

Article

Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report.

Published in:

2020

By:

Aubanel, Marjorie;
Swalduz, Aurélie;
Avrillon, Virginie;
Doublet, Louis;
Mastroianni, Bénédicte;
Neidhardt-Bérard, Eve-Marie;
Pérol, Maurice

Publication type:

Case Study

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.

Published in:

2020

By:

Gobbini, Elisa;
Toffart, Anne Claire;
Pérol, Maurice;
Assié, Jean-Baptiste;
Duruisseaux, Michaël;
Coupez, Dahna;
Dubos, Catherine;
Westeel, Virginie;
Delaunay, Myriam;
Guisier, Florian;
Veillon, Rémi;
Gounant, Valérie;
Giroux Leprieur, Etienne;
Vanel, François-Roger;
Chaabane, Nouha;
Dansin, Eric;
Babey, Hélène;
Decroisette, Chantal;
Barlesi, Fabrice;
Daniel, Catherine

Publication type:

journal article

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Published in:

2018

By:

Hirsch, Fred R.;
Kerr, Keith M.;
Bunn Jr, Paul A.;
Kim, Edward S.;
Obasaju, Coleman;
Pérol, Maurice;
Bonomi, Philip;
Bradley, Jeffrey D.;
Gandara, David;
Jett, James R.;
Langer, Corey J.;
Natale, Ronald B.;
Novello, Silvia;
Paz-Ares, Luis;
Ramalingam, Suresh S.;
Reck, Martin;
Reynolds, Craig H.;
Smit, Egbert F.;
Socinski, Mark A.;
Spigel, David R.

Publication type:

journal article

Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.

Published in:

2018

By:

Ramalingam, Suresh S.;
Pérol, Maurice;
Reck, Martin;
Kowalyszyn, Ruben Dario;
Gautschi, Oliver;
Kimmich, Martin;
Eun Kyung Cho;
Czyzewicz, Grzegorz;
Grigorescu, Alexandru;
Karaseva, Nina;
Dakhil, Shaker;
Pablo Lee;
Zimmerman, Annamaria;
Sashegyi, Andreas;
Alexandris, Ekaterine;
Carter, Gebra Cuyun;
Winfree, Katherine B.;
Garon, Edward B.;
Cho, Eun Kyung;
Lee, Pablo

Publication type:

journal article

Diffuse interstitial lung disease linked to vandetanib.

Published in:

2012

By:

Ernesto S;
Arpin D;
Nesme P;
Pérol M;
Ernesto, Sylvie;
Arpin, Dominique;
Nesme, Pascale;
Pérol, Maurice

Publication type:

journal article

Are Clinical Guidelines Applied in Routine Daily Practice? A French Regional Survey of Physicians' Clinical Practices in Lung Cancer Management (EPOTRA).

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 5, p. 298, doi. 10.1016/j.cllc.2011.04.003

By:

Couraud, Sébastien;
Fournel, Pierre;
Moro-Sibilot, Denis;
Pérol, Maurice;
Souquet, Pierre-Jean

Publication type:

Article

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.

Published in:

2022

By:

Takam Kamga, Paul;
Swalduz, Aurélie;
Costantini, Adrien;
Julié, Catherine;
Emile, Jean-François;
Pérol, Maurice;
Avrillon, Virginie;
Ortiz-Cuaran, Sandra;
De Saintigny, Pierre;
Giroux-Leprieur, Etienne

Publication type:

Correction Notice

The safety and efficacy of erlotinib and ramucirumab combination in EGFR-mutant non-small-cell lung cancer.

Published in:

Expert Review of Anticancer Therapy, 2021, v. 21, n. 10, p. 1071, doi. 10.1080/14737140.2021.1958679

By:

Boussageon, Maxime;
Swalduz, Aurélie;
Pérol, Maurice

Publication type:

Article

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.

Published in:

Cancers, 2022, v. 14, n. 7, p. 1751, doi. 10.3390/cancers14071751

By:

Descourt, Renaud;
Pérol, Maurice;
Rousseau-Bussac, Gaëlle;
Planchard, David;
Mennecier, Bertrand;
Wislez, Marie;
Cadranel, Jacques;
Cortot, Alexis Benjamin;
Guisier, Florian;
Galland, Loïck;
Do, Pascal;
Schott, Roland;
Dansin, Éric;
Arrondeau, Jennifer;
Auliac, Jean-Bernard;
Geier, Margaux;
Chouaïd, Christos

Publication type:

Article

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.

Published in:

2014

By:

Borget, Isabelle;
Pérol, Maurice;
Pérol, David;
Lavolé, Armelle;
Greillier, Laurent;
Dô, Pascal;
Westeel, Virginie;
Crequit, Jacky;
Léna, Hervé;
Monnet, Isabelle;
Le Caer, Hervé;
Fournel, Pierre;
Falchero, Lionel;
Poudenx, Michel;
Vaylet, Fabien;
Chabaud, Sylvie;
Vergnenegre, Alain;
Zalcman, Gérard;
Chouaïd, Christos;
IFCT-GFPC investigators

Publication type:

journal article

Immunothérapie et hospitalisation à domicile.

Published in:

Revue Immunité & Cancer, 2022, v. 6, n. 2, p. 90

By:

PÉROL, Maurice

Publication type:

Article

Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.

Published in:

BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02500-w

By:

Esnault, Cyril;
Baschet, Louise;
Barbet, Vanessa;
Chenuc, Gaëlle;
Pérol, Maurice;
Thokagevistk, Katia;
Pau, David;
Monnereau, Matthias;
Bosquet, Lise;
Filleron, Thomas

Publication type:

Article

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin--gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-953

By:

Borget, Isabelle;
Pérol, Maurice;
Pérol, David;
Lavolé, Armelle;
Greillier, Laurent;
Dô, Pascal;
Westeel, Virginie;
Crequit, Jacky;
Poudenx, Michel;
Vaylet, Fabien;
Chabaud, Sylvie;
Vergnenegre, Alain;
Zalcman, Gérard;
Chouaïd, Christos

Publication type:

Article